DRC Begins Trial Of Experimental Ebola Treatments As Number Of Cases Surpasses 400

Bloomberg: Democratic Republic of Congo Starts Trial for Ebola Treatment
“The Democratic Republic of Congo on Monday began the first trial to test the effectiveness and safety of four experimental drugs in the treatment of Ebola, according to the World Health Organization…” (Ssuuna, 11/26).

CIDRAP News: Ebola cases surge to 419 as treatment trial launches
“Over the Thanksgiving holiday period and through [Monday], the Democratic Republic of the Congo (DRC) reported 33 more Ebola cases, vaulting the total past 400, as the country’s health officials announced the launch of the first clinical trial of experimental drugs to treat the disease…” (Schnirring, 11/26).

CNN: First-of-its-kind Ebola treatment trial underway in Congo as outbreak surpasses 400 cases
“… ‘While our focus remains on bringing this outbreak to an end, the launch of the randomized control trial in DRC is an important step towards finally finding an Ebola treatment that will save lives,’ WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a statement Monday…” (Howard, 11/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.